Roche’s Xolair reduces reactions to severe food allergies in study
NEW YORK — Xolair, a 20-year-old asthma drug marketed by Roche and Novartis, significantly reduced allergic reactions in people with multiple severe food allergies in a late-stage study, researchers reported…
1
2
PAEC Holds National Field Day on Castor Bean and Sesame at NIAB
Web Desk
- November 20, 2025
- 3 views
3
Kaspersky Sounds Alarm on online shopping and Sale Scams
- November 20, 2025
- 5 views
4
Punjab decides to bring all 23 testing labs under newly established PAFDA
- November 19, 2025
- 9 views
5
6
